Prevalence of blaTEM , blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India

Indian Journal of Pathology and Microbiology

Volumn 57, Issue 2, 2014, Pages 249-254

  Bora, Arijit ^a   Hazarika, Naba Kumar ^b   Shukla, Sanket Kumar ^c   Prasad, Kashi N ^c   Sarma, Jayanta Biswa ^d   Ahmed, Giasuddin ^a  

^a GAUHATI UNIVERSITY   (India)

^b GAUHATI MEDICAL COLLEGE   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Escherichia coli; extended spectrum lactamase; Klebsiella pneumoniae

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG; BETA LACTAMASE; PRIMER DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GENETIC SCREENING; GENOTYPE; INDIA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; TERTIARY CARE CENTER; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

BETA-LACTAMASES; DNA PRIMERS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; TERTIARY CARE CENTERS;

EID: 84903307673     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.134698     Document Type: Article

References (21)

1. Rodríguez-Baño J, Pascual A. Clinical significance of extend ed-spectrum beta-lactamases. Expert Rev Anti Infect Ther 2008;6:671-83.
2. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-86.
3. Naas T, Poirel L, Nordmann P. Minor extended-spectrum betalactamases. Clin Microbiol Infect 2008;14 Suppl 1:42-52.
4. Ehlers MM, Veldsman C, Makgotlho EP, Dove MG, Hoosen AA, Kock MM. Detection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko Academic Hospital. FEMS Immunol Med Microbiol 2009;56:191-6.
5. Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int J Antimicrob Agents 2009;34:544-9.
6. Collee JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. 14th ed. Edinburgh: Churchill Livingstone; 1996.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty First Informational Supplement M100-S21. Wayne, PA, USA: CLSI; 2011.
8. Sharma J, Sharma M, Ray P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J Med Res 2010;132:332-6.
9. Lee SH, Kim JY, Lee SK, Jin W, Kang SG, Lee KJ. Discriminatory detection of extended-spectrum beta-lactamases by restriction fragment length dimorphism-polymerase chain reaction. Lett Appl Microbiol 2000;31:307-12.
10. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003;47:3724-32. (Pubitemid 37484979)
11. Raghunath D. Emerging antibiotic resistance in bacteria with special reference to India. J Biosci 2008;33:593-603.
12. Datta S, Wattal C, Goel N, Oberoi JK, Raveendran R, Prasad KJ. A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Res 2012;135:907-12.
13. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India 2010;58 Suppl:32-6.
14. Savard P, Perl TM. A call for action: Managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings. Curr Opin Infect Dis 2012;25:371-7.
15. Pitout JD. The latest threat in the war on antimicrobial resistance. Lancet Infect Dis 2010;10:578-9.
16. Rawat D, Nair D. Extended-spectrum ®-lactamases in gram negative bacteria. J Glob Infect Dis 2010;2:263-74.
17. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008;8:159-66. (Pubitemid 351249250)
18. Jorgensen JH, McElmeel ML, Fulcher LC, Zimmer BL. Detection of CTX-M-Type extended-spectrum beta-lactamase (ESBLs) by testing with MicroScan overnight and ESBL confirmation panels. J Clin Microbiol 2010;48:120-3.
19. Manoharan A, Premalatha K, Chatterjee S, Mathai D, SARI Study Group. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their in vitro antimicrobial susceptibility. Indian J Med Microbiol 2011;29:161-4.
20. Goyal A, Prasad KN, Prasad A, Gupta S, Ghoshal U, Ayyagari A. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors. Indian J Med Res 2009;129:695-700.
21. Shahid M, Singh A, Sobia F, Rashid M, Malik A, Shukla I, et al. blaCTX-M, blaTEM, and blaSHV in Enterobacteriaceae from North-Indian tertiary hospital: High occurrence of combination genes. Asian Pac J Trop Med 2011;4:101-5.